MedTrace Logo

Outcomes of Transcatheter Aortic Valve Implantation in Management of Severe Symptomatic Aortic Stenosis

NCT03633383 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 50

Last updated 2018-08-16

No results posted yet for this study

Summary

TAVI is still a relatively new technique that is emerging with advance in the percutaneous and implantable valve technology. Despite its safe use in inoperable and high risk patients with severe symptomatic aortic valve stenosis, minimizing complications, predictors of outcomes and approach preference is still an area of study. Here we decided to study the outcomes of patients undergoing TAVI, different approaches used and their subsequent results and complications.

Conditions

  • Aortic Valve Stenosis

Interventions

DEVICE

Transcatheter aortic valve

Self-expandable aortic valve prothesis

Sponsors & Collaborators

  • Assiut University

    lead OTHER

Principal Investigators

  • Ahmed Ghoneim, Professor · Assiut University

  • Hussien Elkhayat, Lecturer · Assiut University

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-08-31
Primary Completion
2020-12-31
Completion
2021-01-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03633383 on ClinicalTrials.gov